860 The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model

860 The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model

Bibliographic Details
Main Authors:	Kyong Hwa Park, Eunkyo Joung, Hunwoo Shin, Hun Jung, Jinho Kang, Byung cheol Ahn, Eunjung Jung
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

776 The anti-tumor activity of HER-2/neu ICD therapeutic cancer vaccine (AST-301, pNGVL3-hICD) in Her2-expressed gastric cancer xenograft model
by: Gyeong Seok Jo, et al.
Published: (2021-11-01)

Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy
by: Rodrigues Loreta M, et al.
Published: (2012-05-01)

The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice
by: Lyndsey A. Reich, et al.
Published: (2023-02-01)

Comparison of Expression Profiles of Metastatic versus Primary Mammary Tumors in MMTV-Wnt-1 and MMTV-Neu Transgenic Mice
by: Shixia Huang, et al.
Published: (2008-02-01)

Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer
by: Sara J. Felts, et al.
Published: (2015-04-01)

1422 Th1-specific TROP2 vaccine (AST-07X) elicits strong antigen-specific T cell responses in vitro
by: Eunkyo Joung, et al.
Published: (2023-11-01)

Promotion of breast cancer by β-Hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice
by: Matsumura Fumio, et al.
Published: (2007-07-01)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
by: Wei Li, et al.
Published: (2022-09-01)

BIIB021: A novel inhibitor to heat shock protein 90–addicted oncology
by: Liang Yan, et al.
Published: (2017-04-01)

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.
by: Jason P Holland, et al.
Published: (2010-01-01)

The universe of Hsp90
by: Stankiewicz Marta, et al.
Published: (2012-02-01)

Cryo-EM structure of the agonist-bound Hsp90-XAP2-AHR cytosolic complex
by: Jakub Gruszczyk, et al.
Published: (2022-11-01)

RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response.
by: Fang Guo, et al.
Published: (2012-01-01)

Restriction of MMTV by APOBEC3
by: Kraase Martin, et al.
Published: (2011-12-01)

817 AST-201 (pUMVC3-hIGFBP2 N-terminus) demonstrates anti-tumor effect in an ovarian cancer mouse model
by: Mary L Disis, et al.
Published: (2023-11-01)

Haymon d’Auxerre (fl. 840-860)
by: Sumi Shimahara
Published: (2004-08-01)

Mouse Mammary Tumor Virus (MMTV) and MMTV-like Viruses: An In-depth Look at a Controversial Issue
by: Francesca Parisi, et al.
Published: (2022-05-01)

Role of HSP90 in Cancer
by: Bereket Birbo, et al.
Published: (2021-09-01)

Organismal Roles of Hsp90
by: Patricija van Oosten-Hawle
Published: (2023-01-01)

Role of HSP90 in Cancer
by: Birbo, Bereket, et al.
Published: (2022)

Role of HSP90 in Cancer
by: Birbo, Bereket, et al.
Published: (2021)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
by: Cheng Chang, et al.
Published: (2023-01-01)

The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas
by: Michio eSuzuki, et al.
Published: (2015-04-01)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
by: Ting Li, et al.
Published: (2018-04-01)

Heterologous Hsp90 promotes phenotypic diversity through network evolution.
by: Tracy Chih-Ting Koubkova-Yu, et al.
Published: (2018-11-01)

Unplanned Readmissions after Spine Surgery: A Single-Center Prospective Analysis of a 90-Day Model in 2,860 Cases
by: Mahender Avinash, et al.
Published: (2020-02-01)

Inhibition of Hsp90 in Streptomyces coelicolor
by: Wu, Katherine A. (Katherine Ann)
Published: (2007)

Control of canalization and evolvability by Hsp90.
by: Claire C Milton, et al.
Published: (2006-12-01)

Hsp90 the concertmaster: tuning transcription
by: Nidhi eKhurana, et al.
Published: (2015-04-01)

Functions and Therapeutic Potential of Extracellular Hsp60, Hsp70, and Hsp90 in Neuroinflammatory Disorders
by: Giusi Alberti, et al.
Published: (2021-01-01)

Bacterial Hsp90 Facilitates the Degradation of Aggregation-Prone Hsp70–Hsp40 Substrates
by: Bruno Fauvet, et al.
Published: (2021-04-01)

Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
by: Stefan Tukaj, et al.
Published: (2022-08-01)

Distinct roles of molecular chaperones HSP90α and HSP90β in the biogenesis of KCNQ4 channels.
by: Yanhong Gao, et al.
Published: (2013-01-01)

Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients
by: Zarema Albakova, et al.
Published: (2022-04-01)

A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90).
by: Dea Shahinas, et al.
Published: (2013-01-01)

C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
by: Yingjuan Fan, et al.
Published: (2017-01-01)

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex
by: Shurong Qin, et al.
Published: (2022-02-01)

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
by: Li Zihai, et al.
Published: (2010-10-01)

1421 Th1-specific epitope selection for an off-the-shelf type KRAS cancer vaccine: epitopes of non-mutated lesion
by: Eunkyo Joung, et al.
Published: (2023-11-01)

MMTV-related sequences in feline breast carcinomas
by: Pavlov Vladislav A, et al.
Published: (2009-09-01)